Search
for

    Sort by

    Research 151–180 of 1000+

    1. A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata Archives of dermatological research · 2018 · 42 citations
    2. Alopecia areata: A review Journal of the Saudi Society of Dermatology & Dermatologic Surgery · 2013 · 29 citations
    3. Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents Journal of Investigative Dermatology Symposium Proceedings · 2017 · 28 citations
    4. Rethinking the classification of alopecia areata Journal of the American Academy of Dermatology · 2018 · 13 citations
    5. Successful treatment of resistant alopecia areata with a phototoxic dose of ultraviolet A after topical 8‐methoxypsoralen application Photodermatology, photoimmunology & photomedicine · 2011 · 12 citations
    6. Response of alopecia areata of the beard to oral tofacitinib Journal of the American Academy of Dermatology · 2019 · 11 citations
    7. Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata Journal of the European Academy of Dermatology and Venereology · 2018 · 11 citations
    8. Weekly azathioprine pulse versus betamethasone oral mini-pulse in the treatment of moderate-to-severe alopecia areata Indian Journal of Dermatology · 2019 · 10 citations
    9. Wharton’s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata Advances in Clinical and Experimental Medicine · 2021 · 6 citations
    10. Study on Serum Vitamin D in Alopecia Areata Patients Journal of Nepal Health Research Council · 2019 · 5 citations
    11. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review. PubMed · 2018 · 5 citations
    12. European expert consensus statement on the systemic treatment of alopecia areata 2024 · 4 citations
    13. Not just thinning: A case of alopecia universalis after mild COVID-19 JAAD Case Reports · 2022 · 2 citations
    14. Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study SKIN The Journal of Cutaneous Medicine · 2025 · 1 citations
    15. 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss Journal of The American Academy of Dermatology · 2022 · 1 citations
    16. Alopecia areata and vitamin D: Is there any association? Journal of The American Academy of Dermatology · 2017 · 1 citations
    17. Dupilumab Combined with Topical 5% Minoxidil for Severe Alopecia Areata in a 2-Year-Old Child with Type 2 Immune Features: A Case Report Clinical Cosmetic and Investigational Dermatology · 2026
    18. Dupilumab Combined with Topical 5% Minoxidil for Severe Alopecia Areata in a 2-Year-Old Child with Type 2 Immune Features: A Case Report DOAJ (DOAJ: Directory of Open Access Journals) · 2026
    19. Impact of Disease History on the Efficacy of Ritlecitinib in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study JID Innovations · 2026
    20. Comparative Efficacy of Microneedling with and without Topical Vitamin D3 in Localized Alopecia areata Pakistan Journal of Health Sciences · 2026
    21. Early Hair Regrowth With Adjunctive Secretome Therapy in Severe Patchy Alopecia Areata Academia Open · 2026
    22. Upadacitinib for Severe Alopecia Areata in Adults and Adolescents JAMA Dermatology · 2026
    23. AYURVEDIC MANAGEMENT OF INDRALUPTA(ALOPECIA AREATA): A CASE REPORT International journal of applied ayurved research. · 2026
    24. P146 A multicentre retrospective study evaluating the real-world efficacy and safety of ritlecitinib in the treatment of alopecia areata British Journal of Dermatology · 2026
    25. Rapid Hair Regrowth in Localized Alopecia Areata Following Low-Dose Intralesional Corticosteroid Journal of Asia Pacific Aesthetic Sciences · 2026
    26. Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial British Journal of Dermatology · 2026
    27. Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control Clinical Cosmetic and Investigational Dermatology · 2026
    28. SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES International Journal of Innovative Technologies in Social Science · 2025
    29. EVALUATION OF THE EFFICACY OF PIX LIQUIDA FOR ALOPECIA AREATA: A CASE REPORT ˜The œBioscan. · 2025
    30. CLINICAL INSIGHTS FROM “A STUDY TO EVALUATE THE EFFICACY OF PIX LIQUIDA FOR INDIVIDUALS SUFFERING FROM ALOPECIA AREATA”: A CASE REPORT ˜The œBioscan. · 2025